Insider Transactions last 24 months for Ocular Therapeutix, Inc.  -  NSDQ: OCUL

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Nayak SanjayChief Strategy Officer02/23/2026DSDirectCOM1,759$8.28$14,564.52330,653
Heier Jeffrey S.Chief Scientific Officer02/23/2026DSDirectCOM3,057$8.28$25,311.96323,368
Kaiser PeterChief Development Officer02/23/2026DSDirectCOM2,810$8.28$23,266.80269,108
Dugel PravinSee Remarks02/23/2026DSDirectCOM20,056$8.28$166,063.683,013,022
Lindstrom Richard L MdDirector02/20/2026APDirectCOM60,229$7.66$461,354.14246,933
Waheed NadiaChief Medical Officer02/20/2026DSDirectCOM3,510$7.74$27,167.40314,907
Waheed NadiaChief Medical Officer02/12/2026DSDirectCOM7,863$9.04$71,081.52318,417
Dugel PravinSee Remarks02/12/2026DSDirectCOM124,882$9.04$1,128,933.283,033,078
Nayak SanjayChief Strategy Officer02/12/2026DSDirectCOM10,348$9.04$93,545.92332,412
Notman DonaldChief Operating Officer02/12/2026DSDirectCOM11,446$9.04$103,471.84366,356
Notman DonaldChief Operating Officer02/04/2026DSDirectCOM6,035$8.54$51,538.90377,802
Notman DonaldChief Operating Officer02/02/2026DSDirectCOM5,455$9.14$49,858.70383,837
Robinson David WayneGlobal CCO01/21/2026AADirectCOM136,000$0.00$0.00136,000
Notman DonaldSee Remarks01/02/2026AADirectCOM79,112$0.00$0.00389,292
Heier Jeffrey S.Chief Scientific Officer01/02/2026AADirectCOM79,112$0.00$0.00326,425
Waheed NadiaChief Medical Officer01/02/2026AADirectCOM79,112$0.00$0.00326,280
Saroj NamrataChief Business Officer01/02/2026AADirectCOM79,112$0.00$0.00254,620
Kaiser PeterChief Development Officer01/02/2026AADirectCOM79,112$0.00$0.00271,918
Nayak SanjayChief Strategy Officer01/02/2026AADirectCOM64,900$0.00$0.00342,760
Meyers Steve LawrenceChief Commercial Officer01/02/2026AADirectCOM64,900$0.00$0.00217,628
Anderman ToddChief Legal Officer01/02/2026AADirectCOM64,900$0.00$0.00152,468
Dugel PravinSee Remarks11/26/2025AGIndirectCOM49,754$0.00$0.00300,115
Dugel PravinSee Remarks11/26/2025DGIndirectCOM49,754$0.00$0.000
Heier Jeffrey S.Chief Scientific Officer11/24/2025DSDirectCOM3,469$12.04$41,766.76245,940
Kaiser PeterChief Development Officer11/24/2025DSDirectCOM3,007$12.02$36,144.14191,433
1   2  3  4  Next Last  You are at page 1 of 4 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel